Worldwide Market Reports added Latest Research Report titled “Cyazofamid Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026”.

Cyazofamid is the International Organization for Standardization (ISO)–approved common name for 4-chloro-2-cyano-N, N-dimethyl-5-p-tolylimidazole-1-sulfonamide. It belongs to the chemical class Cyanoimidazole and is used in production of pesticides. It is used for preventing diseases caused by oomycete fungi. Cyazofamid has biochemical mode of action, which operates by inhibiting any stage of fungal development. Furthermore, it has limited systemic activity, which makes it protectant fungicide to be applied by ground or aerial spray. The product controls early and late blight on tomatoes and potatoes and downy mildew on cucurbit vegetables.

Request Sample Copy of the Business Report :https://www.worldwidemarketreports.com/sample/143636

It was first produced and developed by ISK Biosciences Corporation Concord, Ohio in the U.S. According to ISK Biosciences Corporation registered manufacturing, end-use product of the chemical is Ranman 400SC, which is a suspension concentrate with 34.5% active ingredient. Ranman provides good to very good control of downy mildew with protectant, antisporulant, and perhaps limited post-infection activity, with high risk of disease resistance development. It represents a new class of chemistry for use in grapes. For better results, it should be used in a rotational program with other downy mildew fungicides. Increasing incidences of fungal diseases on crops such as tomato, carrot, potato, lettuce, cucurbit, and peas is driving growth of the global cyazofamid market, owing its efficiency in preventing fungal crop diseases.

According to the U.S Environmental Protection Agency (EPA), technical grade cyazofamid has acute to moderate toxicity in oral, dermal, and inhalation tests. It can cause eye and skin irritation, leading to several allergies. This toxic nature of the chemical used in pesticides is estimated to be a major factor restraining growth of global cyazofamid market, as it possess severe health risk. Also, according to EPA, cyazofamid may be carcinogenic, as indicated in the rat and the mouse carcinogenicity studies. It is classified as not likely to be carcinogenic to humans based on the lack of evidence of carcinogenicity in both rats and mouse.

Get discount on this report : https://www.worldwidemarketreports.com/discount/143636

Cyazofamid has applications in downy mildew, oomycetes diseases, and others. North America is leading region in the global cyazofamid market, followed by Asia Pacific due to presence of major manufacturers in this region. Manufacturers operating in global cyazofamid market include Ishihara Sangyo Kaisha and Rudong Zhongyi.

**If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR :

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

U.S

Tel: +1 415 871 0703

Email: [email protected]

WEBSITE : https://www.worldwidemarketreports.com/